Federation Des Caisses Desjardins Du Quebec Athersys, Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $17.5 Billion
  • Q2 2024

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Aug 14, 2024
SELL
$0.17 - $4.5 $170 - $4,500
-1,000 Closed
0 $0
Q1 2022

Aug 14, 2024
BUY
$0.6 - $1.06 $600 - $1,060
1,000 New
1,000 $606,000
Q2 2021

Aug 30, 2024
BUY
$1.41 - $1.94 $1,410 - $1,940
1,000 New
1,000 $1.44 Million
Q1 2021

Aug 30, 2024
BUY
$1.61 - $2.77 $483 - $831
300 Added 8.57%
3,800 $6.84 Million
Q3 2020

Aug 30, 2024
BUY
$1.91 - $3.08 $1,337 - $2,156
700 Added 25.0%
3,500 $6.83 Million
Q2 2020

Aug 30, 2024
BUY
$1.97 - $3.98 $3,546 - $7,164
1,800 Added 180.0%
2,800 $7.73 Million
Q4 2018

Aug 30, 2024
BUY
$1.41 - $2.16 $1,410 - $2,160
1,000 New
1,000 $1.44 Million
Q4 2017

Aug 30, 2024
BUY
$1.65 - $2.45 $1,650 - $2,450
1,000
1,000 $1.81 Million

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email